Aperion Biologics, Inc. — Regulation A 1-A/A
Aperion Biologics, Inc. of SAN ANTONIO, TX filed a Regulation A 1-A/A with the SEC on 2015-11-10. Aggregate offering: $20.0M (Tier 2). Industry: Other.
Offering
- Filed: 2015-11-10
- Form: 1-A/A
- Accession: 0001144204-15-064076
- Tier: Tier 2
- Total aggregate offering: $20.0M
- Issuer portion: $20.0M
- Price per security: $8.0000
- Securities offered: Equity (common or preferred stock)
- Underwriter: WR Hambrecht & Co LLC
- Broker-dealer CRD: 45040
- Audit status: Audited
- Auditor: Marcum LLP
- Jurisdictions: 104 states/territories
Issuer
- CIK: 0001439026
- Organized in: DE
- Incorporated: 2008
- Address: 11969 STARCREST DR, SAN ANTONIO, TX, 78247
- Phone: 210-858-7056
- Employees: 3 full-time
Financial snapshot (as filed)
- Total assets: $402K
- Cash & equivalents: $259K
- Total liabilities: $15.6M
- Revenues: $27K
- Net income: $-1.9M
People (1)
| Name | Role | Location |
|---|
| Daniel R. Lee | Signer | SAN ANTONIO, TX |
Other Reg A filings by this issuer (9)
More